Barbara Merelli
Bg
Bergamo, 24129, Italy
Bergamo, 24129, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 16, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2026
Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
Journal: The New England journal of medicine
Published: October 22, 2025
Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.
Journal: Lancet (London, England)
Published: April 13, 2025
Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP-MADAM (Maximing ADjuvAnt MAP): Interim Analysis.
Journal: Cancers
Published: October 09, 2024
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 29, 2024
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Journal: The New England journal of medicine
Published: June 20, 2024
A Case of Polyserositis, Chylous Ascites and Hepatitis Induced by Immune Checkpoint Inhibitors.
Journal: European journal of case reports in internal medicine
Published: December 17, 2023
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 02, 2023
Pancreatic ductal adenocarcinoma complete regression after preoperative chemotherapy: Surgical results in a small series.
Journal: Cancer treatment and research communications
Published: August 07, 2023
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 28, 2023
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 28, 2022
Last Updated: 09/26/2026